RYTM vs RYAM: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

RYTM has stronger fundamentals based on our AI analysis.

RYTM
RHYTHM PHARMACEUTICALS, INC.
SELL
78%
Confidence
VS
RYAM
RAYONIER ADVANCED MATERIALS INC.
STRONG SELL
88%
Confidence

RYTM vs RYAM Fundamental Comparison

Metric RYTM RYAM
Revenue $189.8M $1.5B
Net Income $-196.5M $-420.7M
Net Margin -103.6% -28.7%
ROE -141.3% -132.9%
ROA -40.9% -23.9%
Current Ratio 4.41x 1.58x
Debt/Equity 0.73x 2.39x
EPS $-3.11 $-6.33

Green = Better metric | Red = Weaker metric

View Full RYTM Analysis →
View Full RYAM Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

RYTM vs AAPL RYAM vs MSFT RYTM vs GOOGL RYAM vs AMZN

RYTM vs RYAM: Frequently Asked Questions

Is RYTM or RYAM a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), RYTM has stronger fundamentals. RYTM is rated SELL (78% confidence) while RYAM is rated STRONG SELL (88% confidence). This is not investment advice.

How does RYTM compare to RYAM fundamentally?

RHYTHM PHARMACEUTICALS, INC. has ROE of -141.3% vs RAYONIER ADVANCED MATERIALS INC.'s -132.9%. Net margins are -103.6% vs -28.7% respectively.

Which stock pays higher dividends, RYTM or RYAM?

RYTM has a dividend yield of N/A or no dividend while RYAM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in RYTM or RYAM for long term?

For long-term investing, consider that RYTM has SELL rating with 78% confidence, while RYAM has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about RYTM vs RYAM?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RYTM vs RYAM, the AI consensus favors RYTM based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.